Educational & Clinical Layer
Strapi CMS · Scientific Database
- →Compendial monographs & HPLC data
- →Historical Bencao & sRNA Atlas
Commercial Storefront Layer
Shopify / Custom Next.js Store
- →Approved structure-function claims
- →Batch-specific CoA downloads
- →B2B Doctor Portal · B2C Retail
FDA Legal Decoupling Boundary — no buy buttons, no product links cross the two layers. Educational monographs and the commercial storefront live on fully isolated URL routes.
Structure-Function Claims
DSHEA permits statements describing how an ingredient maintains or affects the structure or function of the body. No pre-market FDA approval required when substantiated and carrying the mandatory DSHEA disclaimer.
"supports cognitive focus and healthy stress response"
Unapproved Disease Claims
Under Section 201(g)(1)(B) of the FD&C Act, products marketed to diagnose, cure, mitigate, treat, or prevent a disease are legally classified as drugs. Without an approved NDA or active IND, this is an unapproved, misbranded new drug subject to warning letters, seizures, or injunctions.
"treats ADHD" · "reduces anxiety disorders"
The Legal Decoupling Rule
The Trap
Placing a retail "Add to Cart" button directly alongside research articles or historical Bencao texts detailing disease treatments causes the FDA to treat those articles as legal product labeling, converting the supplement into an unapproved new drug.
The Platform Solution
Educational monographs live on an isolated route /monographs/[slug] served by a headless Strapi CMS with zero purchasing mechanisms. Commercial store pages /store/[sku] carry only approved structure-function copy and link clinical detail to batch-specific CoAs verifying USP <561> pesticide and heavy-metal compliance.
Practitioner Gating for Bulk Botanicals
Unprocessed bulk raw materials (e.g., 50lb drums) lack standard consumer supplement labeling. Gating bulk orders behind automated CMS NPPES NPI lookup and Celery OCR license verification creates a closed B2B distribution channel, satisfying federal cGMP requirements under 21 CFR Part 111 while ensuring bulk materials move under professional clinical oversight.